Good morning and welcome to Markets Desk, your midday read on what's moving markets and why.
Eli Lilly is the equity story of the session, with shares surging in premarket trade after late-stage trial results for its next-generation weight-loss drug cleared the bar analysts had set. This is not a minor catalyst — it reinforces Lilly's position at the front of the GLP-one race and signals the pipeline behind tirzepatide has real commercial legs ahead.
Turning to the macro pressure building in transport, the International Air Transport Association is warning that airline profits are set to roughly halve this year as the global fuel bill rises by one hundred billion dollars. Willie Walsh put it plainly — the question is how long travelers and shippers absorb those costs before demand softens, and that answer will define the sector's second half.
And in the cybersecurity space, Palo Alto Networks is giving back some of its extraordinary gains after a fifty-seven percent surge through May. The pullback in June reflects a familiar dynamic — AI-driven momentum stocks run hard, then face a reckoning when valuations outpace near-term earnings visibility. The underlying thesis on AI security remains intact, but price matters.
That's the tape. Markets Desk, signing off the floor.
